The cognitive impact of anticholinergics: a clinical review

Noll Campbell, Malaz Boustani, Tony Limbil, Carol Ott, Chris Fox, Ian Maidment, Cathy C. Schubert, Stephanie Munger, Donna Fick, David Miller, Rajesh Gulati

Research output: Contribution to journalArticle

Abstract

Context: The cognitive side effects of medications with anticholinergic activity have been documented among older adults in a variety of clinical settings. However, there has been no systematic confirmation that acute or chronic prescribing of such medications lead to transient or permanent adverse cognitive outcomes.
Objective: Evaluate the existing evidence regarding the effects of anticholinergic medications on cognition in older adults.
Data sources: We searched the MEDLINE, OVID, and CINAHL databases from January, 1966 to January, 2008 for eligible studies.
Study selection: Studies were included if the anticholinergic activity was systematically measured and correlated with standard measurements of cognitive performance. Studies were excluded if they reported case studies, case series, editorials, and review articles.
Data extraction: We extracted the method used to determine anticholinergic activity of medications and its association with cognitive outcomes.
Results: Twenty-seven studies met our inclusion criteria. Serum anticholinergic assay was the main method used to determine anticholinergic activity. All but two studies found an association between the anticholinergic activity of medications and either delirium, cognitive impairment or dementia.
Conclusions: Medications with anticholinergic activity negatively affect the cognitive performance of older adults. Recognizing the anticholinergic activity of certain medications may represent a potential tool to improve cognition.
LanguageEnglish
Pages225-233
Number of pages9
JournalClinical Interventions in Aging
Volume4
DOIs
Publication statusPublished - May 2009

Fingerprint

Cholinergic Antagonists
Cognition
Delirium
Information Storage and Retrieval
MEDLINE
Dementia
Databases
Serum

Bibliographical note

© 2009 Campbell et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.

Keywords

  • cholinergic antagonists
  • cognition disorders
  • delirium
  • humans
  • anticholinergic activity
  • cognitive impairment
  • elderly

Cite this

Campbell, N., Boustani, M., Limbil, T., Ott, C., Fox, C., Maidment, I., ... Gulati, R. (2009). The cognitive impact of anticholinergics: a clinical review. Clinical Interventions in Aging, 4, 225-233. https://doi.org/10.2147/CIA.S5358
Campbell, Noll ; Boustani, Malaz ; Limbil, Tony ; Ott, Carol ; Fox, Chris ; Maidment, Ian ; Schubert, Cathy C. ; Munger, Stephanie ; Fick, Donna ; Miller, David ; Gulati, Rajesh. / The cognitive impact of anticholinergics : a clinical review. In: Clinical Interventions in Aging. 2009 ; Vol. 4. pp. 225-233.
@article{aa04fe40d6f646c4a7e5fa6ab718280f,
title = "The cognitive impact of anticholinergics: a clinical review",
abstract = "Context: The cognitive side effects of medications with anticholinergic activity have been documented among older adults in a variety of clinical settings. However, there has been no systematic confirmation that acute or chronic prescribing of such medications lead to transient or permanent adverse cognitive outcomes.Objective: Evaluate the existing evidence regarding the effects of anticholinergic medications on cognition in older adults.Data sources: We searched the MEDLINE, OVID, and CINAHL databases from January, 1966 to January, 2008 for eligible studies.Study selection: Studies were included if the anticholinergic activity was systematically measured and correlated with standard measurements of cognitive performance. Studies were excluded if they reported case studies, case series, editorials, and review articles.Data extraction: We extracted the method used to determine anticholinergic activity of medications and its association with cognitive outcomes.Results: Twenty-seven studies met our inclusion criteria. Serum anticholinergic assay was the main method used to determine anticholinergic activity. All but two studies found an association between the anticholinergic activity of medications and either delirium, cognitive impairment or dementia.Conclusions: Medications with anticholinergic activity negatively affect the cognitive performance of older adults. Recognizing the anticholinergic activity of certain medications may represent a potential tool to improve cognition.",
keywords = "cholinergic antagonists, cognition disorders, delirium, humans, anticholinergic activity, cognitive impairment, elderly",
author = "Noll Campbell and Malaz Boustani and Tony Limbil and Carol Ott and Chris Fox and Ian Maidment and Schubert, {Cathy C.} and Stephanie Munger and Donna Fick and David Miller and Rajesh Gulati",
note = "{\circledC} 2009 Campbell et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.",
year = "2009",
month = "5",
doi = "10.2147/CIA.S5358",
language = "English",
volume = "4",
pages = "225--233",
journal = "Clinical Interventions in Aging",
issn = "1176-9092",
publisher = "Dove Medical Press Ltd.",

}

Campbell, N, Boustani, M, Limbil, T, Ott, C, Fox, C, Maidment, I, Schubert, CC, Munger, S, Fick, D, Miller, D & Gulati, R 2009, 'The cognitive impact of anticholinergics: a clinical review' Clinical Interventions in Aging, vol. 4, pp. 225-233. https://doi.org/10.2147/CIA.S5358

The cognitive impact of anticholinergics : a clinical review. / Campbell, Noll; Boustani, Malaz; Limbil, Tony; Ott, Carol; Fox, Chris; Maidment, Ian; Schubert, Cathy C.; Munger, Stephanie; Fick, Donna; Miller, David; Gulati, Rajesh.

In: Clinical Interventions in Aging, Vol. 4, 05.2009, p. 225-233.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The cognitive impact of anticholinergics

T2 - Clinical Interventions in Aging

AU - Campbell, Noll

AU - Boustani, Malaz

AU - Limbil, Tony

AU - Ott, Carol

AU - Fox, Chris

AU - Maidment, Ian

AU - Schubert, Cathy C.

AU - Munger, Stephanie

AU - Fick, Donna

AU - Miller, David

AU - Gulati, Rajesh

N1 - © 2009 Campbell et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.

PY - 2009/5

Y1 - 2009/5

N2 - Context: The cognitive side effects of medications with anticholinergic activity have been documented among older adults in a variety of clinical settings. However, there has been no systematic confirmation that acute or chronic prescribing of such medications lead to transient or permanent adverse cognitive outcomes.Objective: Evaluate the existing evidence regarding the effects of anticholinergic medications on cognition in older adults.Data sources: We searched the MEDLINE, OVID, and CINAHL databases from January, 1966 to January, 2008 for eligible studies.Study selection: Studies were included if the anticholinergic activity was systematically measured and correlated with standard measurements of cognitive performance. Studies were excluded if they reported case studies, case series, editorials, and review articles.Data extraction: We extracted the method used to determine anticholinergic activity of medications and its association with cognitive outcomes.Results: Twenty-seven studies met our inclusion criteria. Serum anticholinergic assay was the main method used to determine anticholinergic activity. All but two studies found an association between the anticholinergic activity of medications and either delirium, cognitive impairment or dementia.Conclusions: Medications with anticholinergic activity negatively affect the cognitive performance of older adults. Recognizing the anticholinergic activity of certain medications may represent a potential tool to improve cognition.

AB - Context: The cognitive side effects of medications with anticholinergic activity have been documented among older adults in a variety of clinical settings. However, there has been no systematic confirmation that acute or chronic prescribing of such medications lead to transient or permanent adverse cognitive outcomes.Objective: Evaluate the existing evidence regarding the effects of anticholinergic medications on cognition in older adults.Data sources: We searched the MEDLINE, OVID, and CINAHL databases from January, 1966 to January, 2008 for eligible studies.Study selection: Studies were included if the anticholinergic activity was systematically measured and correlated with standard measurements of cognitive performance. Studies were excluded if they reported case studies, case series, editorials, and review articles.Data extraction: We extracted the method used to determine anticholinergic activity of medications and its association with cognitive outcomes.Results: Twenty-seven studies met our inclusion criteria. Serum anticholinergic assay was the main method used to determine anticholinergic activity. All but two studies found an association between the anticholinergic activity of medications and either delirium, cognitive impairment or dementia.Conclusions: Medications with anticholinergic activity negatively affect the cognitive performance of older adults. Recognizing the anticholinergic activity of certain medications may represent a potential tool to improve cognition.

KW - cholinergic antagonists

KW - cognition disorders

KW - delirium

KW - humans

KW - anticholinergic activity

KW - cognitive impairment

KW - elderly

UR - http://www.scopus.com/inward/record.url?scp=70049100644&partnerID=8YFLogxK

U2 - 10.2147/CIA.S5358

DO - 10.2147/CIA.S5358

M3 - Article

VL - 4

SP - 225

EP - 233

JO - Clinical Interventions in Aging

JF - Clinical Interventions in Aging

SN - 1176-9092

ER -